| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by LCR.
Page 4: 1 2 3 4 5 6 7 8 9
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 901 | 6 | 33 | 2652 2004 JOURNAL OF THROMBOSIS AND HAEMOSTASIS 2(2):327-334 Kaushal V; Kaushal GP; Melkaveri SN; Mehta P Thalidomide protects endothelial cells from doxorubicin-induced apoptosis but alters cell morphology | 0 | 0 |
| 902 | 5 | 8 | 54 1962 BRITISH JOURNAL OF RADIOLOGY 35(418):687-691 GRAINGER RG; MORRIS AH; WARD P PHOCOMELIC DEFORMITY AND MATERNAL THALIDOMIDE ADMINISTRATION - A REPORT OF 4 CASES | 1 | 2 |
| 903 | 5 | 15 | 97 1962 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 87(24):1232-& LENZ W; KNAPP K DIE THALIDOMID-EMBRYOPATHIE | 48 | 144 |
| 904 | 5 | 6 | 117 1962 LANCET 1(7224):303-& SPEIRS AL THALIDOMIDE AND CONGENITAL ABNORMALITIES | 33 | 76 |
| 905 | 5 | 35 | 153 1962 LANCET 2(7265):1095-& [Anon] THALIDOMIDE AND AFTER | 0 | 0 |
| 906 | 5 | 14 | 171 1962 PEDIATRICS 30(4):654-& TAUSSIG HB THALIDOMIDE AND PHOCOMELIA | 2 | 12 |
| 907 | 5 | 11 | 211 1963 CANCER CHEMOTHERAPY REPORTS (29):99-102 DIPAOLO JA EFFECT OF THALIDOMIDE ON A VARIETY OF TRANSPLANTABLE TUMORS | 0 | 3 |
| 908 | 5 | 20 | 238 1963 LANCET 1(729):1095-& SMITHELLS RW; LECK I INCIDENCE OF LIMB AND EAR DEFECTS SINCE WITHDRAWAL OF THALIDOMIDE | 2 | 24 |
| 909 | 5 | 10 | 251 1963 NEW ENGLAND JOURNAL OF MEDICINE 269(2):92-& TAUSSIG HB EVILS OF CAMOUFLAGE AS ILLUSTRATED BY THALIDOMIDE | 1 | 5 |
| 910 | 5 | 11 | 256 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 112(4):1022-& POLKWILL.A; REUYLLUT.H; BLATTNER RJ ABNORMALITIES IN CHICK EMBRYOS FOLLOWING THALIDOMIDE AND OTHER INSOLUBLE COMPOUNDS IN AMNIOTIC CAVITY | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 911 | 5 | 5 | 278 1964 BULLETIN OF THE JOHNS HOPKINS HOSPITAL 115(3):223-& DEKKER A; MEHRIZI A USE OF THALIDOMIDE AS TERATOGENIC AGENT IN RABBITS | 9 | 15 |
| 912 | 5 | 14 | 295 1964 NATURE 204(496):939-& TATA JR THALIDOMIDE + INDUCED AMPHIBIAN METAMORPHOSIS | 2 | 3 |
| 913 | 5 | 12 | 320 1965 BRITISH MEDICAL JOURNAL 2(5463):687-& HELLMANN K; DUKE DI; TUCKER DF PROLONGATION OF SKIN HOMOGRAFT SURVIVAL BY THALIDOMIDE | 49 | 73 |
| 914 | 5 | 19 | 342 1965 LANCET 2(7421):1059-& [Anon] ANOTHER CHANCE FOR THALIDOMIDE | 7 | 0 |
| 915 | 5 | 11 | 361 1966 AMERICAN JOURNAL OF NURSING 66(9):2023-2026 SOULES BJ THALIDOMIDE VICTIMS IN A REHABILITATION CENTER | 0 | 0 |
| 916 | 5 | 9 | 372 1966 CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL 8(6):299-& CAZORT RJ; SONG YK A TRIAL OF THALIDOMIDE IN PROGRESSIVE LEPRA REACTIONS | 9 | 11 |
| 917 | 5 | 8 | 427 1967 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 48(6):579-& VICKERS TH CONCERNING MORPHOGENESIS OF THALIDOMIDE DYSMELIA IN RABBITS | 12 | 18 |
| 918 | 5 | 6 | 428 1967 BRITISH MEDICAL JOURNAL 4(5578):536-& [Anon] THALIDOMIDE IN LEPROSY | 0 | 0 |
| 919 | 5 | 12 | 434 1967 JOURNAL OF ANIMAL SCIENCE 26(5):1082-& GRAVES CN; SALISBUR.GW; LODGE JR MAMMALIAN SPERMATOZOAN METABOLISM IN PRESENCE OF THALIDOMIDE | 1 | 1 |
| 920 | 5 | 24 | 443 1967 SPERIMENTALE 117(6):465-& LAI P; PALMIERI G TERATOGENIC EFFECTS OF THALIDOMIDE IN CHICKEN AND RABBIT | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 921 | 5 | 7 | 447 1968 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 102(8):1179-& BLAKE DA; FLEISCHE.CA; WYNN RL; GUSDON JP; COHEN C THALIDOMIDE SOLUTION | 0 | 0 |
| 922 | 5 | 45 | 456 1968 BULLETIN DU CANCER 55(3):413-& BAROCHE C ACTIONS OF THALIDOMIDE ON DROSOPHILA WITH REGARD TO DEVELOPMENT AND TUMORIGENESIS - COMPARISONS WITH EFFECT OF POTASSIUM PHTHALATE AND SOME NON-PHTHALATE COMPOUNDS | 1 | 1 |
| 923 | 5 | 19 | 457 1968 CANADIAN JOURNAL OF ANIMAL SCIENCE 48(3):285-& KONDRA PA; SELL JL; MCKIRDY JA EFFECT OF THALIDOMIDE ON EMBRYONIC AND POST-EMBRYONIC DEVELOPMENT OF CHICK | 0 | 0 |
| 924 | 5 | 8 | 473 1968 TRANSPLANTATION 6(3):476-& MOUZAS GL; GERSHON RK EFFECT OF THALIDOMIDE ON SKIN ALLOGRAFTS IN MICE - SURVIVAL OF GRAFTS | 8 | 9 |
| 925 | 5 | 22 | 500 1970 CLINICAL AND EXPERIMENTAL IMMUNOLOGY 7(2):241-& COULSON AS; SUMMERS LJ; LINDAHLK.K; TUCKER D; HELLMANN K EFFECT OF 2 SOLUBLE THALIDOMIDE DERIVATIVES ON LYMPHOCYTE STIMULATION | 16 | 17 |
| 926 | 5 | 24 | 550 1972 DEVELOPMENTAL BIOLOGY 28(1):61-& LASH JW; SAXEN L HUMAN TERATOGENESIS - IN-VITRO STUDIES ON THALIDOMIDE-INHIBITED CHONDROGENESIS | 9 | 26 |
| 927 | 5 | 7 | 553 1972 INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY 10(4):316-& THOMAS BP; VARIA MR; ANSARI MM; MEMON GN LACK OF THALIDOMIDE INDUCED APLASIA IN REGENERATING TAIL OF LIZARD, HEMIDACTYLUS-FLAVIVIRDIS | 0 | 0 |
| 928 | 5 | 12 | 560 1972 TERATOLOGY 5(2):233-& SCHUMACHER HJ; WILSON JG; TERAPANE J; JORDAN RR TERATOGENIC ACTIVITY OF A THALIDOMIDE ANALOG, EM12, IN RABBITS, RATS, AND MONKEYS | 14 | 32 |
| 929 | 5 | 9 | 614 1975 LANCET 1(7906):560-560 [Anon] POSTSCRIPT TO THALIDOMIDE | 0 | 0 |
| 930 | 5 | 16 | 642 1977 BRITISH JOURNAL OF SURGERY 64(3):203-204 SHAND JEG; BREMNER DN AGENESIS OF VERMIFORM APPENDIX IN A THALIDOMIDE CHILD | 4 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 931 | 5 | 17 | 647 1977 EXPERIENTIA 33(10):1384-1386 PETTER C EARLY FETAL THROMBOSIS INDUCED BY THALIDOMIDE IN MOUSE - POSSIBLE EXPLANATION FOR TERATOGENICITY | 7 | 11 |
| 932 | 5 | 16 | 663 1978 ARCHIV DER PHARMAZIE 311(9):779-785 PISCHEK G; FIEBRICH F; KOCH H THALIDOMIDE ANALOGS, .10. TRANSPLACENTAL DISTRIBUTION KINETICS OF BIGLUMIDE IN MOUSE | 0 | 3 |
| 933 | 5 | 6 | 672 1978 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 239(16):1608-1609 ARCHER J THALIDOMIDE AND NEUROLOGICAL DAMAGE REVISITED | 0 | 0 |
| 934 | 5 | 8 | 742 1981 ARCHIVES OF DERMATOLOGICAL RESEARCH 271(2):165-170 KNOP J; HAPPLE R; BONSMANN G; VAKILZADEH F; MACHER E TREATMENT OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE | 16 | 17 |
| 935 | 5 | 36 | 744 1981 ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH 31-1(2):315-320 FLOHE L; DRAEGER E; FRANKUS E; GRAUDUMS I; GUNZLER WA; HELM FC; KUUTTISAVOLAINEN ER STUDIES ON THE HYPOTHETICAL RELATIONSHIP OF THALIDOMIDE-INDUCED EMBRYOPATHY AND COLLAGEN BIOSYNTHESIS | 0 | 10 |
| 936 | 5 | 20 | 746 1981 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 98(4):1029-1034 BRAUN AG; DAILEY JP THALIDOMIDE METABOLITE INHIBITS TUMOR-CELL ATTACHMENT TO CONCANAVALIN A COATED SURFACES | 6 | 16 |
| 937 | 5 | 10 | 781 1982 DEVELOPMENT GROWTH & DIFFERENTIATION 24(2):217-222 MCBRIDE WG; STOKES PA; VARDY PH MATERNAL THALIDOMIDE TREATMENT AND CELL-DIVISION IN CULTURED RABBIT EMBRYOS - AUTOMATED IMAGE-ANALYSIS OF AUTORADIOGRAPHS | 2 | 2 |
| 938 | 5 | 8 | 804 1983 BRITISH JOURNAL OF DERMATOLOGY 108(4):461-466 KNOP J; BONSMANN G; HAPPLE R; LUDOLPH A; MATZ DR; MIFSUD EJ; MACHER E THALIDOMIDE IN THE TREATMENT OF 60 CASES OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS | 78 | 109 |
| 939 | 5 | 14 | 822 1983 HAUTARZT 34(4):168-170 SHESKIN J; MUCKTER H; FRANKUS E SUPIDIMIDE, A NON-TERATOGENIC ANALOG OF THALIDOMIDE IN THE TREATMENT OF LEPRA REACTIONS | 2 | 2 |
| 940 | 5 | 14 | 860 1984 MUSCLE & NERVE 7(5):362-368 SCHWAB BW; AREZZO JC; PALDINO AM; FLOHE L; MATTHIESSEN T; SPENCER PS RABBIT SURAL NERVE RESPONSES TO CHRONIC TREATMENT WITH THALIDOMIDE AND SUPIDIMIDE | 4 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 941 | 5 | 20 | 890 1985 INTERNATIONAL JOURNAL OF LEPROSY AND OTHER MYCOBACTERIAL DISEASES 53(2):201-205 MONCADA B; BARANDA ML; GONZALEZAMARO R; URBINA R; LOREDO CE THALIDOMIDE - EFFECT ON T-CELL SUBSETS AS A POSSIBLE MECHANISM OF ACTION | 31 | 42 |
| 942 | 5 | 8 | 900 1985 LANCET 2(8450):331-331 CRAWFORD CL THALIDOMIDE AND LEPROSY | 1 | 1 |
| 943 | 5 | 19 | 912 1986 ARCHIVES OF INTERNAL MEDICINE 146(5):878-881 JORIZZO JL; SCHMALSTIEG FC; SOLOMON AR; CAVALLO T; TAYLOR RS; RUDLOFF HB; SCHMALSTIEG EJ; DANIELS JC THALIDOMIDE EFFECTS IN BEHCETS-SYNDROME AND PUSTULAR VASCULITIS | 25 | 57 |
| 944 | 5 | 10 | 924 1986 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 14(2):282-283 ARONSON IK; WEBER L; WEST D; BUYS C; REDER A; ANTEL J THALIDOMIDE AND LYMPHOCYTE FUNCTION | 6 | 6 |
| 945 | 5 | 17 | 937 1986 ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES 41(11-12):1057-1061 KOCH HP; CZEJKA MJ EVIDENCE FOR THE INTERCALATION OF THALIDOMIDE INTO DNA - CLUE TO THE MOLECULAR MECHANISM OF THALIDOMIDE TERATOGENICITY | 8 | 10 |
| 946 | 5 | 15 | 961 1988 ARCHIVES OF TOXICOLOGY 62(2-3):205-208 HEGER W; KLUG S; SCHMAHL HJ; NAU H; MERKER HJ; NEUBERT D EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES ON THE NON-HUMAN PRIMATE CALLITHRIX-JACCHUS .3. TERATOGENIC POTENCY OF THE EM-12 ENANTIOMERS | 6 | 13 |
| 947 | 5 | 5 | 962 1988 ARTHRITIS AND RHEUMATISM 31(1):145-146 GUTIERREZRODRIGUEZ O; STARUSTABACAL P; GUTIERREZMONTES O THALIDOMIDE-INDUCED NEUROPATHY IN RHEUMATOID-ARTHRITIS PATIENTS | 2 | 4 |
| 948 | 5 | 8 | 965 1988 BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY 95(7):717-719 MAOURIS PG; HIRSCH PJ PREGNANCY IN WOMEN WITH THALIDOMIDE-INDUCED DISABILITIES - CASE-REPORT AND A QUESTIONNAIRE STUDY | 0 | 4 |
| 949 | 5 | 17 | 966 1988 CLINICAL AND EXPERIMENTAL DERMATOLOGY 13(6):408-410 MUNRO CS; COX NH PYODERMA GANGRENOSUM ASSOCIATED WITH BEHCETS SYNDROME - RESPONSE TO THALIDOMIDE | 12 | 19 |
| 950 | 5 | 10 | 1040 1991 BRITISH MEDICAL JOURNAL 303(6809):1062-1063 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 951 | 5 | 7 | 1065 1992 LANCET 339(8792):549-550 BESSIS D; GUILLOT B; MONPOINT S; DANDURAND M; GUILHOU JJ THALIDOMIDE FOR SYSTEMIC LUPUS-ERYTHEMATOSUS | 27 | 31 |
| 952 | 5 | 6 | 1067 1992 LANCET 339(8805):1362-1362 CARMICHAEL AJ; KNIGHT A THALIDOMIDE - A RESTRICTED ROLE | 3 | 5 |
| 953 | 5 | 5 | 1073 1992 NEW ENGLAND JOURNAL OF MEDICINE 327(10):735-735 CRAWFORD CL THALIDOMIDE NEUROPATHY | 5 | 6 |
| 954 | 5 | 7 | 1077 1992 TRANSPLANTATION PROCEEDINGS 24(6):2624-2625 OSTRAAT O; EKBERG H; SCHATZ H; RIESBECK K; ERIKSSON T THALIDOMIDE PROLONGS GRAFT-SURVIVAL IN RAT CARDIAC TRANSPLANTS | 9 | 9 |
| 955 | 5 | 5 | 1127 1994 BRITISH MEDICAL JOURNAL 308(6941):1437-1438 CRAWFORD CL SAFETY OF THALIDOMIDE | 4 | 4 |
| 956 | 5 | 12 | 1148 1994 LANCET 343(8895):432-433 JAKEMAN P; SMITH WCS THALIDOMIDE IN LEPROSY REACTION | 8 | 14 |
| 957 | 5 | 25 | 1178 1995 BRITISH JOURNAL OF CANCER 72(2):339-343 CHING LM; XU ZF; GUMMER BH; PALMER BD; JOSEPH WR; BAGULEY BC EFFECT OF THALIDOMIDE ON TUMOR-NECROSIS-FACTOR PRODUCTION AND ANTITUMOR-ACTIVITY INDUCED BY 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID | 25 | 41 |
| 958 | 5 | 6 | 1182 1995 CLINICAL AND EXPERIMENTAL DERMATOLOGY 20(1):85-85 MISERY L; PEGUETNAVARRO J; THIVOLET J; FAURE M; SCHMITT D; CLAUDY AL THALIDOMIDE DOES NOT AFFECT IN-VITRO MIXED SKIN CELL LYMPHOCYTE REACTIONS | 0 | 1 |
| 959 | 5 | 10 | 1187 1995 DIGESTIVE DISEASES AND SCIENCES 40(5):1147-1148 NAUM SM; MOLLOY PJ; KANIA RJ; MCGARR J; VANTHIEL DH USE OF THALIDOMIDE IN TREATMENT AND MAINTENANCE OF IDIOPATHIC ESOPHAGEAL ULCERS IN HIV+ INDIVIDUALS | 7 | 11 |
| 960 | 5 | 5 | 1195 1995 GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE 19(1):128-129 SIRE S; FRAISSE P; REY D; JACQUEMIN C; KEMPF G; PARTISANI M; LANG JM EFFECTIVENESS OF THALIDOMIDE IN THE TREATMENT OF ESOPHAGEAL ULCERS IN AIDS | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 961 | 5 | 19 | 1201 1995 JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS 674(2):287-292 Weinz C; Blaschke G Investigation of the in vitro biotransformation and simultaneous enantioselective separation of thalidomide and its neutral metabolites by capillary electrophoresis | 11 | 24 |
| 962 | 5 | 5 | 1215 1995 MOLECULAR MEDICINE TODAY 1(5):210-210 STEWART A IS THALIDOMIDE A MUTAGEN | 0 | 0 |
| 963 | 5 | 14 | 1234 1996 ANNALS OF THE RHEUMATIC DISEASES 55(11):833-836 Huizinga TWJ; Dijkmans BAC; vanderVelde EA; Kraan TCTMV; Verweij CL; Breedveld FC An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis | 20 | 37 |
| 964 | 5 | 21 | 1244 1996 BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 224(2):426-430 Miyachi H; Azuma A; Hioki E; Iwasaki S; Kobayashi Y; Hashimoto Y Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production | 15 | 25 |
| 965 | 5 | 13 | 1255 1996 CLINICAL INFECTIOUS DISEASES 23(3):501-503 Soler RA; Howard M; Brink NS; Gibb D; Tedder RS; Nadal D Regression of AIDS-related Kaposi's sarcoma during therapy with thalidomide | 24 | 31 |
| 966 | 5 | 25 | 1291 1996 NEUROREPORT 7(12):1881-1886 Kanbayashi T; Nishino S; Tafti M; Hishikawa Y; Dement WC; Mignot E Thalidomide, a hypnotic with immune modulating properties, increases cataplexy in canine narcolepsy | 1 | 6 |
| 967 | 5 | 5 | 1326 1997 CLINICAL CHEMISTRY 43(6):1094-1095 Eriksson T; Bjorkman S Handling of blood samples for determination of thalidomide | 6 | 6 |
| 968 | 5 | 9 | 1372 1997 NATURE 385(6614):303-304 Wnendt S; Zwingenberger K Thalidomide's chirality | 9 | 16 |
| 969 | 5 | 32 | 1384 1997 RESPIRATORY MEDICINE 91(1):31-39 Tavares JL; Wangoo A; Dilworth P; Marshall B; Kotecha S; Shaw RJ Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages | 23 | 38 |
| 970 | 5 | 19 | 1397 1998 ANNALS OF INTERNAL MEDICINE 128(6):494-495 Ehrlich GE Behcet disease and the emergence of thalidomide | 4 | 19 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 971 | 5 | 15 | 1407 1998 BIOLOGICAL & PHARMACEUTICAL BULLETIN 21(6):638-640 Ishikawa M; Kanno S; Takayanagi M; Takayanagi Y; Sasaki K Thalidomide promotes the release of tumor necrosis factor-alpha (TNF-alpha) and lethality by lipopolysaccharide in mice | 5 | 6 |
| 972 | 5 | 7 | 1418 1998 BONE MARROW TRANSPLANTATION 22(9):933-934 Sastry PSRK; Powles RL Thalidomide for chronic GVHD | 0 | 0 |
| 973 | 5 | 5 | 1461 1998 LANCET 352(9127):544-545 Stambe C; Wicks IP TNF alpha and response of treatment-resistant adult-onset Still's disease to thalidomide | 10 | 24 |
| 974 | 5 | 12 | 1547 1999 GUT 45(3):463-464 Ollivier S; Bonnet J; Lemann M; Coffin JC; Modigliani R; Jian R; Bertheau P; Flejou JF Idiopathic giant oesophageal ulcer in an immunocompetent patient. The efficacy of thalidomide treatment | 1 | 2 |
| 975 | 5 | 17 | 1550 1999 IMMUNOPHARMACOLOGY 43(1):59-64 Dunzendorfer S; Herold M; Wiedermann CJ Inducer-specific bidirectional regulation of endothelial interleukin-8 production by thalidomide | 8 | 8 |
| 976 | 5 | 14 | 1579 1999 MEDICAL HYPOTHESES 53(1):76-77 Sastry PSRK Inhibition of TNF-alpha synthesis with thalidomide for prevention of acute exacerbations and altering the natural history of multiple sclerosis | 5 | 7 |
| 977 | 5 | 8 | 1596 1999 PHARMACOLOGY & TOXICOLOGY 85(2):103-104 Huang PHT; McBride WG; Tuman WG Interaction of thalidomide with DNA of rabbit embryos: A possible explanation for its immunosuppressant and teratogenic effects | 3 | 3 |
| 978 | 5 | 11 | 1602 1999 SLEEP 22(1):113-115 Kanbayashi T; Shimizu T; Takahashi Y; Kitajima T; Takahashi K; Saito Y; Hishikawa Y Thalidomide increases both REM and stage 3-4 sleep in human adults: A preliminary study | 8 | 10 |
| 979 | 5 | 5 | 1608 2000 AIDS 14(12):1859-1861 Gori A; Rossi MC; Marchetti G; Trabattoni D; Molteni C; Cogliati M; Bandera A; Clerici M; Franzetti F Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease | 5 | 7 |
| 980 | 5 | 15 | 1692 2000 CHROMATOGRAPHIA 52(7-8):455-458 Alvarez C; Sanchez-Brunete JA; Torrado-Santiago S; Cadorniga R; Torrado JJ Enantioselective separation of thalidomide on on immobilized alpha(l)-acid glycoprotein chiral stationary phase | 0 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 981 | 5 | 42 | 1789 2000 SEMINARS IN HEMATOLOGY 37(1):35-39 Alexanian R; Anderson KC; Barlogie B; Stirling DI; Thomas DA Thalidomide in hematologic malignancies: Future directions | 5 | 5 |
| 982 | 5 | 13 | 1811 2001 ANNALS OF ONCOLOGY 12(7):991-995 Dimopoulos MA; Zervas K; Kouvatseas G; Galani E; Grigoraki V; Kiamouris C; Vervessou E; Samantas E; Papadimitriou C; Economou O; Gika D; Panayiotidis P; Christakis I; Anagnostopoulos N Thalidomide and dexamethasone combination for refractory multiple myeloma | 29 | 40 |
| 983 | 5 | 14 | 1813 2001 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 45(5):1547-1549 Juffermans NP; Verbon A; Schultz MJ; Hack CE; van Deventer SJH; Speelman P; van der Poll T Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens | 2 | 2 |
| 984 | 5 | 12 | 1887 2001 BRITISH JOURNAL OF HAEMATOLOGY 113(2):422-424 Blade J; Perales M; Rosinol L; Tuset M; Montoto S; Esteve O; Cobo F; Villela L; Rafel M; Nomdedeu B; Montserrat E Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas | 18 | 19 |
| 985 | 5 | 21 | 1937 2001 HAEMATOLOGICA 86(4):404-408 Hus M; Dmoszynska A; Soroka-Wojtaszko M; Jawniak D; Legiec W; Ciepnuch H; Hellmann A; Wolska-Smolen T; Skotnicki A; Manko J; Polish Multiple Myeloma Study Grp Thalidomide treatment of resistant or relapsed multiple myeloma patients | 23 | 35 |
| 986 | 5 | 20 | 1942 2001 HAUTARZT 52:962-965 Hoch O; Muller S; Buttner G; Mensing H Thalidomide in the treatment of cutaneous and systemic sarcoidosis | 3 | 5 |
| 987 | 5 | 15 | 1943 2001 HAUTARZT 52:966-969 Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide | 0 | 0 |
| 988 | 5 | 29 | 1968 2001 JOURNAL OF NEURO-ONCOLOGY 55(1):11-17 Mawrin C; Aumann V; Kirches E; Schneider-Stock R; Scherlach C; Vogel S; Mittler U; Dietzmann K; Krause G; Weis S Gliomatosis cerebri: Post-mortem molecular and immunohistochemical analyses in a case treated with thalidomide | 0 | 4 |
| 989 | 5 | 7 | 2003 2001 SCIENTIST 15(2):1-+ Lewis R The return of thalidomide | 0 | 1 |
| 990 | 5 | 5 | 2054 2002 BLOOD 99(11):4247-4248 Urbauer E; Kaufmann H; Nosslinger T; Raderer M; Drach J Thromboembolic events during treatment with thalidomide | 12 | 17 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 991 | 5 | 5 | 2146 2002 BRITISH MEDICAL JOURNAL 325(7374):1245-1245 Ashby J; Tinwell H Thalidomide is not a human mutagen | 0 | 0 |
| 992 | 5 | 25 | 2180 2002 EUROPEAN JOURNAL OF HEART FAILURE 4(4):455-460 Vescovo G; Ravara B; Angelini A; Sandri M; Carraro U; Ceconi C; Libera LD Effect of thalidomide on the skeletal muscle in experimental heart failure | 1 | 2 |
| 993 | 5 | 40 | 2213 2002 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 8(5):256-259 Barthel HR; Charrier U; Kramer M; Loch C Successful treatment of idiopathic febrile panniculitis (Weber-Christian disease) with thalidomide in a patient having failed multiple other medical therapies | 0 | 0 |
| 994 | 5 | 24 | 2255 2002 LEUKEMIA & LYMPHOMA 43(1):133-137 Strupp C; Aivado M; Germing U; Gattermann N; Haas R Angioimmunoblastic lymphadenopathy (AILD) may respond to thalidomide treatment: Two case reports | 1 | 4 |
| 995 | 5 | 23 | 2258 2002 LEUKEMIA & LYMPHOMA 43(6):1267-1271 Badros A; Morris C; Zangari M; Barlogie B; Tricot G Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia | 3 | 3 |
| 996 | 5 | 25 | 2284 2002 RADIOLOGE 42(3):222-230 Scherer A; Strupp C; Wittsack HJ; Engelbrecht V; Willers R; Germing U; Gattermann N; Haas R; Modder U Dynamic contrast-enhanced MRI for the evaluation of bone marrow microcirculation in hematologic malignancies before and during thalidomide therapy | 0 | 0 |
| 997 | 5 | 31 | 2287 2002 SEMINARS IN ONCOLOGY 29(6):34-38 Durie BGM Low-dose thalidomide in myeloma: Efficacy and biologic significance | 5 | 7 |
| 998 | 5 | 9 | 2295 2003 ACTA HAEMATOLOGICA 109(3):153-155 Tsiara S; Chaidos A; Kapsali H; Tzouvara E; Bourantas KL Thalidomide administration for the treatment of resistant plasma cell leukemia | 0 | 0 |
| 999 | 5 | 11 | 2409 2003 BRITISH JOURNAL OF DERMATOLOGY 148(5):1060-1061 Tjiu JW; Hsiao CH; Tsai TF Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment | 0 | 0 |
| 1000 | 5 | 12 | 2413 2003 BRITISH JOURNAL OF HAEMATOLOGY 121(1):101-103 Steurer M; Sudmeier I; Stauder R; Gastl G Thromboembolic events in patients with myelodysplastic syndrome receiving thalidomide in combination with darbepoietin-alpha | 3 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1001 | 5 | 6 | 2417 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(1):160-161 Harris E; Behrens J; Samson D; Rahemtulla A; Russell NH; Byrne JL Use of thalidomide in patients with myeloma and renal failure may be associated with unexplained hyperkalaemia | 2 | 3 |
| 1002 | 5 | 34 | 2425 2003 CANCER 97(5):1234-1241 Cortes J; Kantarjian H; Albitar M; Thomas D; Faderl S; Koller C; Garcia-Manero G; Giles F; Andreeff M; O'Brien S; Keating M; Estey E A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome | 1 | 5 |
| 1003 | 5 | 27 | 2426 2003 CANCER CHEMOTHERAPY AND PHARMACOLOGY 52:S16-S23 Hashimoto Y Structural development of synthetic retinoids and thalidomide-related molecules | 0 | 0 |
| 1004 | 5 | 39 | 2430 2003 CELLULAR AND MOLECULAR BIOLOGY 49(7):1117-1124 Ezell TN; Maloney N; Githua JW; Taylor LD Exposure to the anti-TNF-alpha drug thalidomide induces apoptotic cell death in human T leukemic cells | 0 | 0 |
| 1005 | 5 | 20 | 2440 2003 CLINICAL LYMPHOMA 4(1):32-35 Zangari M; Barlogie B; Thertulien R; Jacobson J; Eddleman P; Fink L; Fassas A; Van Rhee F; Talamo G; Lee CK; Tricot G Thalidomide and deep vein thrombosis in multiple myeloma: Risk factors and effect on survival | 1 | 4 |
| 1006 | 5 | 10 | 2451 2003 DRUG METABOLISM AND DISPOSITION 31(8):1072-1072 Zhou SF CYP1A1-mediated activation of thalidomide and suppression of embryo fibroblast proliferation | 0 | 0 |
| 1007 | 5 | 10 | 2465 2003 INTERNAL MEDICINE 42(7):605-608 Hayashi T; Yamaguchi I; Saitoh H; Takagi M; Nonaka Y; Nomura T Thalidomide treatment for immunoglobulin D multiple myeloma in a patient on chronic hemodialysis | 1 | 1 |
| 1008 | 5 | 41 | 2470 2003 INTERNATIONAL JOURNAL OF ONCOLOGY 22(1):165-173 Yata K; Otsuki T; Kurebayashi J; Uno M; Fujii T; Yawata Y; Takata A; Hyodoh F; Sugihara T Expression of angiogenic factors including VEGFs and the effects of hypoxia and thalidomide on human myeloma cells | 2 | 3 |
| 1009 | 5 | 37 | 2479 2003 JOURNAL OF CLINICAL ONCOLOGY 21(13):2551-2557 Danson S; Lorigan P; Arance A; Clamp A; Ranson M; Hodgetts J; Lomax L; Ashcroft L; Thatcher N; Middleton MR Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma | 0 | 3 |
| 1010 | 5 | 8 | 2517 2003 LEUKEMIA 17(6):1200-1202 Strupp C; Hildebrandt B; Germing U; Haas R; Gattermann N Cytogenetic response to thalidomide treatment in three patients with myelodysplastic syndrome | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1011 | 5 | 8 | 2518 2003 LEUKEMIA 17(8):1669-1670 Visani G; Mele A; Malagola M; Isidori A; Finelli C; Piccaluga PP Sequential combination of thalidomide and erythropoietin determines transfusion independence and disease control in idiopathic myelofibrosis previously insensitive to both drugs used as single agents | 1 | 1 |
| 1012 | 5 | 25 | 2535 2003 MEDICAL ONCOLOGY 20(4):397-401 Fraiman G; Ganti AK; Potti A; Mehdi S Angiosarcoma of the small intestine - Possible role for thalidomide? | 0 | 0 |
| 1013 | 5 | 5 | 2577 2004 ANNALS OF ONCOLOGY 15(3):537-537 Fuente N; Mane JM; Barcelo R; Munoz A; Perez-Hoyos T; Lopez-Vivanco G Tumor lysis syndrome in a multiple myeloma treated with thalidomide | 0 | 0 |
| 1014 | 5 | 11 | 2583 2004 ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH 51(3):505-506 Pillemer SR; Leakan RA; Sankar V; Manny J; Baum BJ; Smith J; Chaudhry U; Fox PC; Radfar L; Ligier S; Brennan MT Prominent adverse effects of thalidomide in primary Sjogren's syndrome | 0 | 0 |
| 1015 | 5 | 17 | 2609 2004 CHIRALITY 16:S36-S39 Nakanishi T; Yamakawa N; Asahi T; Shibata N; Ohtani B; Osaka T Chiral discrimination between thalidomide enantiomers using a solid surface with two-dimensional chirality | 0 | 0 |
| 1016 | 5 | 30 | 2631 2004 INTERNATIONAL JOURNAL OF CANCER 110(2):260-265 Kedar I; Mermershtain W; Ivgi H Thalidomide reduces serum C-reactive protein and interleukin-6 and induces response to IL-2 in a fraction of metastatic renal cell cancer patients who failed IL-2-based therapy | 0 | 0 |
| 1017 | 5 | 7 | 2664 2004 LUPUS 13(6):481-482 Pagnoux C; Lutz-Zarrouk V; Michel M; Schaeffer A; Godeau B Cerebral venous thrombosis in a patient with antiphospholipid syndrome treated with thalidomide | 0 | 0 |
| 1018 | 5 | 5 | 2671 2004 MEDICAL JOURNAL OF AUSTRALIA 180(7):366-367 Coutsouvelis J; Corallo CE Thalidomide-induced bradycardia and its management | 0 | 0 |
| 1019 | 4 | 24 | 43 1961 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 134(1):60-& KUHN WL; VANMAANEN EF CENTRAL NERVOUS SYSTEM EFFECTS OF THALIDOMIDE | 8 | 85 |
| 1020 | 4 | 6 | 56 1962 BRITISH MEDICAL JOURNAL (5276):477-& WILLMAN A; DUMOULIN JG THALIDOMIDE (DISTAVAL) AND FOETAL ABNORMALITIES | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1021 | 4 | 4 | 108 1962 JOURNAL OF PEDIATRICS 61(2):318-& BLATTNER RJ THALIDOMIDE STUDIES IN EXPERIMENTAL ANIMALS | 3 | 5 |
| 1022 | 4 | 10 | 139 1962 LANCET 2(7251):336-& [Anon] THALIDOMIDE .2. | 0 | 0 |
| 1023 | 4 | 10 | 166 1962 NEW ENGLAND JOURNAL OF MEDICINE 266(24):1268-& COHEN S THALIDOMIDE POLYNEUROPATHY | 8 | 10 |
| 1024 | 4 | 25 | 187 1963 AMERICAN JOURNAL OF PATHOLOGY 43(6):999-& MARINPADILLA M; BENIRSCHKE K THALIDOMIDE INDUCED ALTERATIONS IN BLASTOCYST AND PLACENTA OF ARMADILLO, DASYPUS NOVEMCINCTUS MEXICANUS, INCLUDING A CHORIOCARCINOMA | 6 | 35 |
| 1025 | 4 | 10 | 239 1963 LANCET 1(729):1374-& NARROD SA; KING CTG METABOLIC STUDIES WITH THALIDOMIDE | 4 | 9 |
| 1026 | 4 | 12 | 244 1963 LANCET 2(731):1068-& MILLER ZB INHIBITION OF TISSUE-CULTURE GROWTH BY A SOLUBLE THALIDOMIDE DERIVATIVE | 5 | 9 |
| 1027 | 4 | 8 | 249 1963 NATURE 200(491):1016-& ROE FJC; MITCHLEY BC THALIDOMIDE AND NEOPLASIA | 8 | 13 |
| 1028 | 4 | 17 | 258 1963 PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE 114(2):326-& FRANK O; HUTNER SH; SOBOTKA H; BAKER H TOXICITY TO PROTOZOA OF THALIDOMIDE BREAKDOWN PRODUCTS - COUNTERACTION BY NICOTINIC ACID AND GLUTAMINE | 8 | 12 |
| 1029 | 4 | 4 | 272 1964 BIOCHEMICAL JOURNAL 90(1):P5-& FABRO S; SCHUMACHER H; STAGG BL; SMITH RL; WILLIAMS RT BIOLOGICAL ACTIVITY OF THALIDOMIDE METABOLITES | 11 | 15 |
| 1030 | 4 | 14 | 288 1964 LANCET 1(733):724-& FELISATI D TERATOGENIC ACTION OF THALIDOMIDE | 6 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1031 | 4 | 10 | 301 1964 SCIENCE 143(361):1343-& HIRSCHBERG E; BRYANT S; ULTMANN JE; OSNOS M THALIDOMIDE - EFFECTS ON ENZYMES OF GLUTAMIC ACID METABOLISM IN MICE | 6 | 8 |
| 1032 | 4 | 13 | 317 1965 BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 25(2):338-& SCHUMACHER H; SMITH RL; WILLIAMS RT METABOLISM OF THALIDOMIDE - FATE OF THALIDOMIDE AND SOME OF ITS HYDROLYSIS PRODUCTS IN VARIOUS SPECIES | 59 | 72 |
| 1033 | 4 | 25 | 322 1965 CANADIAN JOURNAL OF BIOCHEMISTRY 43(6):769-& KIM HC; PAIK WK; DIORIO A EFFECT OF THALIDOMIDE AND ITS DERIVATIVES ON THYROXINE-INDUCED METAMORPHOSIS OF TADPOLE | 0 | 1 |
| 1034 | 4 | 7 | 326 1965 CHEMICAL & PHARMACEUTICAL BULLETIN 13(10):1263-& TANAKA A; HASEGAWA A; URAKUBO G METABOLIC FATE OF THALIDOMIDE IN RATS | 6 | 7 |
| 1035 | 4 | 12 | 327 1965 CHEMISTRY & INDUSTRY (24):1030-& SHEALY YF; OPLIGER CE; MONTGOME.JA D-AND 6-THALIDOMIDE | 0 | 16 |
| 1036 | 4 | 22 | 335 1965 HUMANGENETIK 1(6):516-536 NOWACK E CORRELATION BETWEEN THE PERIOD OF THALIDOMIDE-ADMINISTRATION AND EMBRYOPATHY | 19 | 40 |
| 1037 | 4 | 5 | 346 1965 NATURE 205(4977):1241-& PARUPS EV; HOFFMAN I ABSENCE OF GROWTH EFFECTS OF THALIDOMIDE ON HIGHER PLANTS | 0 | 6 |
| 1038 | 4 | 6 | 347 1965 NATURE 208(5016):1208-& FABRO S; SMITH RL; WILLIAMS RT THALIDOMIDE AS A POSSIBLE BIOLOGICAL ACYLATING AGENT | 18 | 30 |
| 1039 | 4 | 5 | 410 1966 VETERINARY RECORD 78(25):883-& JAFFE WP FAILURE OF THALIDOMIDE TO INFLUENCE HOMOGRAFT IMMUNITY IN CHICKENS | 5 | 5 |
| 1040 | 4 | 26 | 412 1967 ACTA NEUROLOGICA SCANDINAVICA S 43:5-& HAFSTROM T POLYNEUROPATHY AFTER NEUROSEDYN (THALIDOMIDE) AND ITS PROGNOSIS | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1041 | 4 | 8 | 430 1967 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 92(47):2186-& LENZ W SENSITIVE PHASE OF THALIDOMIDE EMBRYOPATHIES IN MONKEYS AND MEN | 0 | 1 |
| 1042 | 4 | 22 | 450 1968 ARZNEIMITTEL-FORSCHUNG 18(6):661-& BRODE E EXPERIMENTAL STUDIES ON CYCLIC IMIDES .I. INFLUENCE OF THALIDOMIDE ON PITUITARY-ADRENAL AXIS | 1 | 2 |
| 1043 | 4 | 41 | 478 1969 ARZNEIMITTEL-FORSCHUNG 19(9):1544-& KOCH H INHIBITOR EFFECT OF THALIDOMIDE AND SEVERAL ANALEPTIC DRUGS ON GERMINATION AND EMBRYONIC GROWTH OF LEPIDIUM SATIVUM L | 0 | 8 |
| 1044 | 4 | 12 | 484 1969 FOLIA PRIMATOLOGICA 10(3):195-& BARROW MV; STEFFEK AJ; KING CTG THALIDOMIDE SYNDROME IN RHESUS MONKEYS (MACACA MULATTA) | 4 | 9 |
| 1045 | 4 | 16 | 486 1969 LANCET 1(7597):713-& [Anon] THALIDOMIDE NEUROPATHY | 5 | 0 |
| 1046 | 4 | 10 | 506 1970 JOURNAL OF THE CHEMICAL SOCIETY D-CHEMICAL COMMUNICATIONS (12):778-& ALLEN FH; TROTTER J CRYSTAL AND MOLECULAR STRUCTURE OF THALIDOMIDE | 1 | 0 |
| 1047 | 4 | 15 | 522 1971 EXPERIENTIA 27(6):671-& ECKERT T; DORR NW INTERMOLECULAR INTERACTIONS OF FOLIC ACID WITH N-PHTHALOYL-DL-GLUTAMIC ACID PROBLEM OF TERATOGENIC ACTION OF THALIDOMIDE | 1 | 2 |
| 1048 | 4 | 37 | 525 1971 JOURNAL OF THE CHEMICAL SOCIETY B-PHYSICAL ORGANIC (6):1073-& ALLEN FH; TROTTER J CRYSTAL AND MOLECULAR STRUCTURE OF THALIDOMIDE, N-(ALPHA-GLUTARIMIDO)-PHTHALIMIDE | 5 | 29 |
| 1049 | 4 | 7 | 585 1973 TERATOLOGY 8(2):163-166 KAJII T; KIDA M; TAKAHASH.K EFFECT OF THALIDOMIDE INTAKE DURING 113 HUMAN PREGNANCIES | 8 | 21 |
| 1050 | 4 | 9 | 601 1974 PRACTITIONER 212(1269):296-297 ROE FJC RESEARCH ON ANTICARCINOGENIC EFFECTS OF THALIDOMIDE | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1051 | 4 | 19 | 612 1975 HAUTARZT 26(1):1-5 SHESKIN J THERAPEUTIC EFFECTS OF THALIDOMIDE IN LEPROSY REACTION | 22 | 25 |
| 1052 | 4 | 19 | 650 1977 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 203(1):240-251 FREDERICKSON RCA; SLATER IH; DUSENBERRY WE; HEWES CR; JONES GT; MOORE RA COMPARISON OF THALIDOMIDE AND PENTOBARBITAL - NEW METHODS FOR IDENTIFYING NOVEL HYPNOTIC DRUGS | 0 | 9 |
| 1053 | 4 | 12 | 655 1977 PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON 70(4):225-227 NEWMAN CGH CLINICAL OBSERVATIONS ON THALIDOMIDE SYNDROME | 0 | 13 |
| 1054 | 4 | 28 | 728 1980 INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY 18:403-409 KLASINC L; TRINAJSTIC N; KNOP JV APPLICATION OF PHOTOELECTRON-SPECTROSCOPY TO BIOLOGICALLY-ACTIVE MOLECULES AND THEIR CONSTITUENT PARTS .8. THALIDOMIDE | 0 | 0 |
| 1055 | 4 | 12 | 730 1980 MONATSSCHRIFT KINDERHEILKUNDE 128(1):27-29 MILLER A; SCHMIDT CG; HORWITZ A; KOSENOW W COINCIDENCE OF A THALIDOMIDE-INDUCED MALFORMATION AND A LYMPHOMA OF HIGH MALIGNANCY | 1 | 1 |
| 1056 | 4 | 18 | 759 1981 PATHOLOGIE BIOLOGIE 29(10):601-604 FAURE M; LEJEUNE JP; GAUCHERAND M; THIVOLET J PMN LEUKOCYTES CHEMOTAXIS - INHIBITION BY THALIDOMIDE | 6 | 9 |
| 1057 | 4 | 36 | 765 1981 SCANDINAVIAN JOURNAL OF IMMUNOLOGY 13(6):553-562 SHANNON EJ; MIRANDA RO; MORALES MJ; HASTINGS RC INHIBITION OF DENOVO IGM ANTIBODY-SYNTHESIS BY THALIDOMIDE AS A RELEVANT MECHANISM OF ACTION IN LEPROSY | 32 | 41 |
| 1058 | 4 | 40 | 769 1981 TERATOLOGY 23(3):351-364 NEWMAN LM; HENDRICKX AG FETAL EAR MALFORMATIONS INDUCED BY MATERNAL INGESTION OF THALIDOMIDE IN THE BONNET MONKEY (MACACA, RADIATA) | 2 | 13 |
| 1059 | 4 | 7 | 772 1982 ACTA DERMATO-VENEREOLOGICA 62(5):449-450 BAHMER FA; ZAUN H; LUSZPINSKI P THALIDOMIDE TREATMENT OF RECURRENT ERYTHEMA MULTIFORME | 19 | 25 |
| 1060 | 4 | 10 | 785 1982 NATURWISSENSCHAFTEN 69(4):191-192 KOCHERBECKER U; KOCHER W; OCKENFELS H TERATOGENIC ACTIVITY OF A HYDROLYTIC THALIDOMIDE METABOLITE IN MICE | 3 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1061 | 4 | 17 | 872 1985 ACTA NEUROPATHOLOGICA 65(3-4):285-292 SCHRODER JM; MATTHIESEN T EXPERIMENTAL THALIDOMIDE NEUROPATHY - THE MORPHOLOGICAL CORRELATE OF REDUCED CONDUCTION-VELOCITY | 5 | 7 |
| 1062 | 4 | 17 | 905 1985 PSYCHOPHARMACOLOGY 85(1):47-50 KAITIN KI EFFECTS OF THALIDOMIDE AND PENTOBARBITAL ON NEURONAL-ACTIVITY IN THE PREOPTIC AREA DURING SLEEP AND WAKEFULNESS IN THE CAT | 3 | 6 |
| 1063 | 4 | 5 | 967 1988 DERMATOLOGICA 176(2):107-107 VIRABEN R; DUPRE A ERYTHEMA-NODOSUM FOLLOWING THALIDOMIDE THERAPY FOR BEHCET DISEASE | 1 | 5 |
| 1064 | 4 | 4 | 970 1988 LANCET 1(8577):117-117 LIM SH; MCWHANNELL A; VORA AJ; BOUGHTON BJ SUCCESSFUL TREATMENT WITH THALIDOMIDE OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION | 32 | 35 |
| 1065 | 4 | 8 | 985 1988 TRANSPLANTATION PROCEEDINGS 20(2):226-228 VOGELSANG GB; WELLS MC; SANTOS GW; CHEN TL; HESS AD COMBINATION LOW-DOSE THALIDOMIDE AND CYCLOSPORINE PROPHYLAXIS FOR ACUTE GRAFT-VERSUS-HOST DISEASE IN A RAT MISMATCHED MODEL | 14 | 16 |
| 1066 | 4 | 6 | 990 1989 BONE MARROW TRANSPLANTATION 4(5):598-598 HEATON DC FAILURE OF THALIDOMIDE TO CONTROL BRONCHIOLITIS OBLITERANS POST BONE-MARROW TRANSPLANT | 1 | 3 |
| 1067 | 4 | 5 | 992 1989 BRITISH MEDICAL JOURNAL 298(6671):432-432 YOULE M; CLARBOUR J; FARTHING C; CONNOLLY M; HAWKINS D; STAUGHTON R; GAZZARD B TREATMENT OF RESISTANT APHTHOUS ULCERATION WITH THALIDOMIDE IN PATIENTS POSITIVE FOR HIV ANTIBODY | 56 | 103 |
| 1068 | 4 | 12 | 1031 1990 TERATOLOGY 41(2):241-242 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 1069 | 4 | 10 | 1033 1990 TERATOLOGY 41(2):245-246 STEPHENS TD PROPOSED MECHANISMS OF ACTION IN THALIDOMIDE EMBRYOPATHY | 1 | 3 |
| 1070 | 4 | 8 | 1038 1991 BRITISH MEDICAL JOURNAL 302(6792):1603-1604 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 6 | 7 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1071 | 4 | 10 | 1039 1991 BRITISH MEDICAL JOURNAL 303(6800):470-470 WATERS MFR USE OF THALIDOMIDE IN LEPROSY | 5 | 5 |
| 1072 | 4 | 6 | 1055 1992 BRITISH JOURNAL OF DERMATOLOGY 126(1):92-93 MOISSON YF; JANIER M; CIVATTE J THALIDOMIDE FOR RECURRENT ERYTHEMA MULTIFORME | 9 | 12 |
| 1073 | 4 | 10 | 1061 1992 JOURNAL OF INFECTIOUS DISEASES 166(4):939-940 GEORGHIOU PR; ALLWORTH AM THALIDOMIDE IN PAINFUL AIDS-ASSOCIATED PROCTITIS | 11 | 21 |
| 1074 | 4 | 6 | 1076 1992 TRANSPLANTATION PROCEEDINGS 24(6):2560-2561 ERIKSSON T; RIESBECK K; OSTRAAT O; EKBERG H; BJORKMAN S DRUG EXPOSURE AND FLOW-CYTOMETRY ANALYSES IN A THALIDOMIDE TREATMENT SCHEDULE THAT PROLONGS RAT CARDIAC GRAFT-SURVIVAL | 6 | 7 |
| 1075 | 4 | 5 | 1089 1993 BONE MARROW TRANSPLANTATION 11(3):251-252 LOPEZ J; ULIBARRENA C; GARCIALARANA J; ODRIOZOLA J; DEOTEYZA JP; SASTRE JL; NAVARRO JL THALIDOMIDE AS THERAPY FOR INTESTINAL CHRONIC GVHD | 6 | 9 |
| 1076 | 4 | 6 | 1103 1993 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 28(2):271-272 GHIGLIOTTI G; REPETTO T; FARRIS A; ROY MT; DEMARCHI R THALIDOMIDE - TREATMENT OF CHOICE FOR APHTHOUS ULCERS IN PATIENTS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS | 31 | 39 |
| 1077 | 4 | 10 | 1119 1994 ARCHIVES OF TOXICOLOGY 68(3):203-205 KLUG S; FELIES A; STURJE H; NOGUEIRA AC; NEUBERT R; FRANKUS E EMBRYOTOXIC EFFECTS OF THALIDOMIDE DERIVATIVES IN THE NONHUMAN PRIMATE CALLITHRIX-JACCHUS .5. LACK OF TERATOGENIC EFFECTS OF PHTHALIMIDOPHTHALIMIDE | 4 | 7 |
| 1078 | 4 | 13 | 1144 1994 JOURNAL OF CHEMICAL CRYSTALLOGRAPHY 24(1):95-99 CAIRA MR; BOTHA SA; FLANAGAN DR POLYMORPHISM OF N-(2,6-DIOXO-3-PIPERIDYL)PHTHALIMIDE (THALIDOMIDE) - STRUCTURAL CHARACTERIZATION OF A 2ND MONOCLINIC RACEMIC MODIFICATION | 0 | 2 |
| 1079 | 4 | 22 | 1170 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39(12):2807-2809 PETERSON PK; GEKKER G; BORNEMANN M; CHATTERJEE D; CHAO CC THALIDOMIDE INHIBITS LIPOARABINOMANNAN-INDUCED UP-REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION | 3 | 10 |
| 1080 | 4 | 28 | 1177 1995 BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 28(10):1069-1076 AARESTRUP FM; GONCALVESDACOSTA SC; SARNO EN THE EFFECT OF THALIDOMIDE ON BCG-INDUCED GRANULOMAS IN MICE | 2 | 9 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1081 | 4 | 4 | 1179 1995 BRITISH JOURNAL OF DERMATOLOGY 132(1):168-168 MEUNIER L; MARCK Y; RIBEYRE C; MEYNADIER J ADULT CUTANEOUS LANGERHANS CELL HISTIOCYTOSIS - REMISSION WITH THALIDOMIDE TREATMENT | 9 | 20 |
| 1082 | 4 | 31 | 1194 1995 FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY 12(3-4):165-174 GEIST C; WOHRMANN T; SCHNEIDER J; ZWINGENBERGER K EFFECTS OF THALIDOMIDE ON THE LOCAL SHWARTZMAN REACTION IN MICE AND RABBITS | 6 | 8 |
| 1083 | 4 | 18 | 1206 1995 JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY 33(2):380-382 MANDERS SM; KOSTMAN JR; MENDEZ L; RUSSIN VL THALIDOMIDE-RESISTANT HIV-ASSOCIATED APHTHAE SUCCESSFULLY TREATED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR | 1 | 7 |
| 1084 | 4 | 18 | 1214 1995 MOLECULAR MEDICINE 1(4):384-397 TRAMONTANA JM; UTAIPAT U; MOLLOY A; AKARASEWI P; BURROUGHS M; MAKONKAWKEYOON S; JOHNSON B; KLAUSNER JD; ROM W; KAPLAN G THALIDOMIDE TREATMENT REDUCES TUMOR-NECROSIS-FACTOR-ALPHA PRODUCTION AND ENHANCES WEIGHT-GAIN IN PATIENTS WITH PULMONARY TUBERCULOSIS | 60 | 130 |
| 1085 | 4 | 11 | 1216 1995 NATURE 375(6531):453-453 ASHBY J; TINWELL H IS THALIDOMIDE MUTAGENIC | 7 | 11 |
| 1086 | 4 | 25 | 1236 1996 ANTICANCER RESEARCH 16(6B):3673-3677 Gutman M; Szold A; Ravid A; Lazauskas T; Merimsky O; Klausner JM Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo | 16 | 23 |
| 1087 | 4 | 5 | 1238 1996 ARCHIVES OF DISEASE IN CHILDHOOD 74(1):64-65 Soler RA; Migliorati C; vanWaes H; Nadal D Thalidomide treatment of mucosal ulcerations in HIV infection | 11 | 14 |
| 1088 | 4 | 17 | 1251 1996 CANCER LETTERS 101(1):21-24 Pollard M Thalidomide promotes metastasis of prostate adenocarcinoma cells (PA-III) in L-W rats | 8 | 12 |
| 1089 | 4 | 22 | 1268 1996 IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 18(1):59-72 Shannon EJ; Sandoval F Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells | 21 | 24 |
| 1090 | 4 | 5 | 1287 1996 NATURE MEDICINE 2(2):132-132 Crawford CL Thalidomide neuropathy | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1091 | 4 | 5 | 1327 1997 CLINICAL CHEMISTRY 43(6):1095-1096 Lyon AW; Raisys VA Handling of blood samples for determination of thalidomide - Respond | 0 | 0 |
| 1092 | 4 | 4 | 1354 1997 JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY 15(5):392-392 Sharp M; Getty J; Klausner JD Thalidomide use is associated with weight gain in HIV-1-positive clients | 2 | 2 |
| 1093 | 4 | 29 | 1379 1997 NEUROSCIENCE LETTERS 234(2-3):123-126 Boireau A; Bordier F; Dubedat P; Peny C; Imperato A Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice | 0 | 9 |
| 1094 | 4 | 24 | 1398 1998 ANTICANCER RESEARCH 18(6A):4409-4413 Browne WL; Wilson WR; Baguley BC; Ching LM Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid | 5 | 13 |
| 1095 | 4 | 5 | 1400 1998 ARCHIVES OF DERMATOLOGY 134(8):1045-1046 Rousseau L; Beylot-Barry M; Doutre MS; Beylot C Cutaneous sarcoidosis successfully treated with low doses of thalidomide | 12 | 25 |
| 1096 | 4 | 13 | 1409 1998 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 8(19):2669-2674 Muller GW; Shire MG; Wong LM; Corral LG; Patterson RT; Chen YX; Stirling DI Thalidomide analogs and PDE4 inhibition | 20 | 31 |
| 1097 | 4 | 5 | 1527 1999 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 17(3):393-393 de Wazieres B; Gil H; Vuitton DA; Dupond JL Treatment of recurrent oro-genital ulceration with low doses of thalidomide | 2 | 3 |
| 1098 | 4 | 10 | 1528 1999 CLINICAL INFECTIOUS DISEASES 28(4):892-894 Ramirez-Amador VA; Esquivel-Pedraza L; Ponce-de-Leon S; Reyes-Teran G; Gonzalez-Guevara M; Ponce-de-Leon S; Sierra-Madero JG Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: A double-blind placebo-controlled clinical trial | 4 | 5 |
| 1099 | 4 | 24 | 1553 1999 INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 80(1):11-16 Arrieta O; Ortiz-Reyes A; Rembao D; Calvillo M; Rivera E; Sotelo J Protective effect of pentoxifylline plus thalidomide against septic shock in mice | 4 | 8 |
| 1100 | 4 | 5 | 1573 1999 LANCET 353(9149):324-324 Klausner JD; Kaplan G; Haslett PAJ Thalidomide in toxic epidermal necrolysis | 7 | 8 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1101 | 4 | 11 | 1582 1999 NATURE 400(6743):419-420 Neubert R; Merker HT; Neubert D Developmental model for thalidomide action | 3 | 4 |
| 1102 | 4 | 13 | 1592 1999 ORGANIC PROCESS RESEARCH & DEVELOPMENT 3(2):139-140 Muller GW; Konnecke WE; Smith AM; Khetani VD A concise two-step synthesis of thalidomide | 5 | 12 |
| 1103 | 4 | 9 | 1607 2000 ACTA DERMATO-VENEREOLOGICA 80(1):24-25 Daly BM; Shuster S Antipruritic action of thalidomide | 3 | 9 |
| 1104 | 4 | 4 | 1624 2000 ARCHIVES OF DERMATOLOGY 136(12):1442-1443 Camisa C; Popovsky JL Effective treatment of oral erosive lichen planus with thalidomide | 6 | 11 |
| 1105 | 4 | 8 | 1677 2000 BLOOD 96(12):3995-3996 Koc S; Leisenring W; Flowers MED; Anasetti C; Deeg HJ; Nash RA; Sanders JE; Witherspoon RP; Appelbaum FR; Storb R; Martin PJ Thalidomide for treatment of patients with chronic graft-versus-host disease | 14 | 23 |
| 1106 | 4 | 4 | 1685 2000 BRITISH JOURNAL OF HAEMATOLOGY 110(3):754-754 Gutheil J; Finucane D Thalidomide therapy in refractory solid tumour patients | 10 | 13 |
| 1107 | 4 | 8 | 1718 2000 GASTROENTEROLOGY 119(2):596-596 Fishman SJ; Feins NR; D'Amato RJ; Folkman J Thalidomide therapy for Crohn's disease | 5 | 12 |
| 1108 | 4 | 9 | 1721 2000 HAEMATOLOGICA 85(10):1111-1112 Pini M; Baraldi A; Pietrasanta D; Allione B; Depaoli L; Salvi F; Levis A Low-dose thalidomide in the treatment of refractory myeloma | 11 | 19 |
| 1109 | 4 | 17 | 1736 2000 JOURNAL OF CHILD NEUROLOGY 15(8):497-503 Schoeman JF; Springer P; Ravenscroft A; Donald PR; Bekker LG; van Rensburg AJ; Hanekom WA; Haslett PAJ; Kaplan G Adjunctive thalidomide therapy of childhood tuberculous meningitis: Possible anti-inflammatory role | 8 | 10 |
| 1110 | 4 | 5 | 1747 2000 JOURNAL OF INFECTIOUS DISEASES 182(2):640-640 Kaplan G Tumor necrosis factor-alpha increased production during thalidomide treatment in patients with tuberculosis and human immunodeficiency virus coinfection - Reply | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1111 | 4 | 10 | 1760 2000 MEDICINA-BUENOS AIRES 60:61-65 Politi PM Thalidomide. Clinical trials in cancer. | 1 | 1 |
| 1112 | 4 | 5 | 1763 2000 MUSCLE & NERVE 23(8):1301-1302 Rao DG; Kane NM; Oware A Thalidomide neuropathy: Role of F-wave monitoring | 5 | 5 |
| 1113 | 4 | 6 | 1769 2000 NEW ENGLAND JOURNAL OF MEDICINE 343(13):972-973 Rajkumar SV; Gertz MA; Witzig TE Life-threatening toxic epidermal necrolysis with thalidomide therapy for myeloma. | 23 | 33 |
| 1114 | 4 | 12 | 1775 2000 ONCOLOGY-NEW YORK 14(12):17-20 Eisen TG Thalidomide in solid tumors: The London experience | 11 | 15 |
| 1115 | 4 | 18 | 1795 2000 TETRAHEDRON LETTERS 41(14):2275-2278 Luzzio FA; Mayorov AV; Figg WD Thalidomide metabolites. Part 1: Derivatives of (+)-2-(N-phthalimido)-gamma-hydroxyglutamic acid | 3 | 7 |
| 1116 | 4 | 7 | 1801 2001 AMERICAN JOURNAL OF GASTROENTEROLOGY 96(4):1305-1306 Ginsburg PM; Hanan I; Ehrenpreis ED Treatment of severe esophageal Crohn's disease with thalidomide | 8 | 10 |
| 1117 | 4 | 18 | 1824 2001 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 7(5):265-273 Arora M; Wagner JE; Davies SM; Blazar BR; Defor T; Enright H; Miller WF; Weisdorf DJ Randomized clinical trial of thalidomide, cyclosporine, and prednisone versus cyclosporine and prednisone as initial therapy for chronic graft-versus-host disease | 8 | 15 |
| 1118 | 4 | 4 | 1880 2001 BONE MARROW TRANSPLANTATION 27(2):229-230 Schlossberg H; Klumpp T; Sabol P; Herman J; Mangan K Severe cutaneous ulceration following treatment with thalidomide for GVHD | 0 | 1 |
| 1119 | 4 | 4 | 1886 2001 BRITISH JOURNAL OF DERMATOLOGY 144(6):1292-1293 Passeron T; Lacour JP; Murr D; Ortonne JP Thalidomide-induced amenorrhoea: two cases | 4 | 4 |
| 1120 | 4 | 26 | 1915 2001 DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT 126(42):1183-1186 Maio G On the history of the Contergan (thalidomide) catastrophe in the light of drug legislation | 0 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1121 | 4 | 10 | 1964 2001 JOURNAL OF INFECTIOUS DISEASES 183(2):343-346 Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C; Natl Inst Allergy Infect Dis AIDS Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers | 1 | 3 |
| 1122 | 4 | 8 | 1991 2001 ONCOLOGY-NEW YORK 15(7):877-878 Govindarajan R Current status of thalidomide in the treatment of cancer - The Rajkumar article reviewed | 0 | 0 |
| 1123 | 4 | 6 | 2032 2002 ANNALS OF ONCOLOGY 13(10):1636-1640 Grover JK; Uppal G; Raina V The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma | 3 | 4 |
| 1124 | 4 | 33 | 2050 2002 BIOORGANIC & MEDICINAL CHEMISTRY 10(9):3067-3073 Lima LM; Castro P; Machado AL; Fraga CAM; Lugnier C; de Moraes VLG; Barreiro EJ Synthesis and anti-inflammatory activity of phthalimide derivatives, designed as new thalidomide analogues | 2 | 6 |
| 1125 | 4 | 4 | 2055 2002 BLOOD 99(11):4248-4248 Lee FC Second response to lower-dose thalidomide in a patient with multiple myeloma | 2 | 2 |
| 1126 | 4 | 23 | 2058 2002 BLOOD 100(4):1168-1171 Zangari M; Siegel E; Barlogie B; Anaissie E; Saghafifar F; Fassas A; Morris C; Fink L; Tricot G Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy | 17 | 31 |
| 1127 | 4 | 20 | 2060 2002 BLOOD 100(6):2263-2265 Neben K; Mytilineos J; Moehler TM; Preiss A; Kraemer A; Ho AD; Opelz G; Goldschmidt H Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma | 9 | 19 |
| 1128 | 4 | 6 | 2135 2002 BRITISH JOURNAL OF DERMATOLOGY 146(6):1112-1113 Pouaha J; Martin S; Reichert-Penetrat S; Trechot P; Barbaud A; Schmutz JL Thalidomide and sexual dysfunction in men | 0 | 0 |
| 1129 | 4 | 5 | 2137 2002 BRITISH JOURNAL OF HAEMATOLOGY 117(4):996-997 Bauduer F Efficacy of thalidomide in the treatment of VAD-refractory plasma cell leukaemia appearing after autologous stem cell transplantation for multiple myeloma | 0 | 0 |
| 1130 | 4 | 4 | 2138 2002 BRITISH JOURNAL OF HAEMATOLOGY 118(1):347-347 Myers B; Dolan G Analysis of durability of response to thalidomide treatment for relapsed myeloma patients | 1 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1131 | 4 | 5 | 2153 2002 CELL SIGNALING, TRANSCRIPTION, AND TRANSLATION AS THERAPEUTIC TARGETS 973:414-418 Jin SH; Il Kim T; Han DS; Shin SK; Kim WH Thalidomide suppresses the interleukin 1 beta-induced NF kappa B signaling pathway in colon cancer cells | 1 | 2 |
| 1132 | 4 | 7 | 2196 2002 HAEMATOLOGICA 87(3):327-328 Corso A; Lorenzi A; Orlandi E; Astori C; Mangiacavalli S; Lazzarino M Advantages of using thalidomide for the management of patients with refractory myeloma | 3 | 4 |
| 1133 | 4 | 4 | 2221 2002 JOURNAL OF CLINICAL ONCOLOGY 20(5):1429-1430 Nathan PD; Gore ME; Eisen TG Unexpected toxicity of combination thalidomide and interferon alfa-2a treatment in metastatic renal cell carcinoma | 7 | 11 |
| 1134 | 4 | 5 | 2222 2002 JOURNAL OF CLINICAL ONCOLOGY 20(8):2212-2212 Cany L; Fitoussi O; Boiron JM; Marit G Tumor lysis syndrome at the beginning of thalidomide therapy for multiple myeloma | 4 | 4 |
| 1135 | 4 | 40 | 2241 2002 JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 27(3-4):497-505 Trapp O; Schoetz G; Schurig V Stereointegrity of thalidomide: gas-chromatographic determination of the enantiomerization barrier | 0 | 2 |
| 1136 | 4 | 16 | 2249 2002 JOURNAL OF THE CHINESE CHEMICAL SOCIETY 49(3):383-385 Chang MY; Chang CH; Chen ST; Chang NC A synthesis of thalidomide | 0 | 9 |
| 1137 | 4 | 26 | 2257 2002 LEUKEMIA & LYMPHOMA 43(2):401-406 Dmoszynska A; Bojarska-Junak A; Domanski D; Rolinski J; Hus M; Soroka-Wojtaszko M Production of proangiogenic cytokines during thalidomide treatment of multiple myeloma | 2 | 6 |
| 1138 | 4 | 6 | 2265 2002 MEDICAL JOURNAL OF AUSTRALIA 177(5):278-278 McBride W Thalidomide and cancer | 1 | 1 |
| 1139 | 4 | 11 | 2271 2002 OBSTETRICS AND GYNECOLOGY 99(1):125-128 Ances BM New concerns about thalidomide | 1 | 3 |
| 1140 | 4 | 17 | 2275 2002 ONCOLOGY-NEW YORK 16(4):23-26 Govindarajan R Irinoteean/Thalidomide in metastatic colorectal cancer | 4 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1141 | 4 | 37 | 2301 2003 AMERICAN JOURNAL OF HEMATOLOGY 73(1):48-53 Lee FC; Merchant SH Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide | 1 | 2 |
| 1142 | 4 | 19 | 2309 2003 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 130(12):1109-1112 Macario-Barrel A; Balguerie X; Joly P Treatment of erosive oral lichen planus with thalidomide | 0 | 0 |
| 1143 | 4 | 9 | 2408 2003 BRITISH JOURNAL OF DERMATOLOGY 148(3):601-602 Worm M; Kolde G Schnitzler's syndrome: successful treatment of two patients using thalidomide | 0 | 0 |
| 1144 | 4 | 12 | 2415 2003 BRITISH JOURNAL OF HAEMATOLOGY 121(5):768-771 Anagnostopoulos A; Weber D; Rankin K; Delasalle K; Alexanian R Thalidomide and dexamethasone for resistant multiple myeloma | 11 | 16 |
| 1145 | 4 | 7 | 2416 2003 BRITISH JOURNAL OF HAEMATOLOGY 122(1):159-160 Santos AB; Llamas P; Roman A; Prieto E; de Ona R; de Velasco JF; Tomas JF Evaluation of thrombophylic states in myeloma patients receiving thalidomide: A reasonable doubt | 1 | 1 |
| 1146 | 4 | 10 | 2419 2003 BRITISH JOURNAL OF HAEMATOLOGY 123(2):305-308 Thompson MA; Witzig TE; Kumar S; Timm MM; Haug J; Fonseca R; Greipp PR; Lust JA; Rajkumar SV Plasma levels of tumour necrosis factor alpha and interleukin-6 predict progression-free survival following thalidomide therapy in patients with previously untreated multiple myeloma | 2 | 4 |
| 1147 | 4 | 12 | 2433 2003 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 21(2):272-272 Meaux-Ruault N; Magy N; Gil H; Dupond JL Efficacy of thalidomide in refractory adult Still's disease: A new case report | 0 | 0 |
| 1148 | 4 | 10 | 2462 2003 HAEMATOLOGICA 88(8):958-960 Corso A; Lorenzi A; Zapposodi P; Invernizzi R; Vanelli L; Lazzarino M Early changes in bone marrow morphology induced by thalidomide in patients with refractory myeloma | 0 | 0 |
| 1149 | 4 | 10 | 2463 2003 HAEMATOLOGICA 88(12):1432-1433 Offidani M; Marconi M; Corvotta L; Olivieri A; Catarini M; Leoni P Thalidomide plus oral melphalan for advanced multiple myeloma: a phase II study | 0 | 1 |
| 1150 | 4 | 9 | 2473 2003 JCR-JOURNAL OF CLINICAL RHEUMATOLOGY 9(2):96-98 Ching DWT; McClintock A; Beswick F Successful treatment with low-dose thalidomide in a patient with both Behcet's disease and complex regional pain syndrome type I - Case report | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1151 | 4 | 37 | 2478 2003 JOURNAL OF CLINICAL ONCOLOGY 21(12):2299-2304 Fine HA; Wen PY; Maher EA; Viscosi E; Batchelor T; Lakhani N; Figg WD; Purow BW; Borkowf CB Phase II trial of thalidomide and carmustine for patients with recurrent high-grade gliomas | 0 | 3 |
| 1152 | 4 | 4 | 2493 2003 JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION 37(4):522-522 Ahmed M; El-Hadi S; Jenkins HR Thalidomide in Crohn disease and the risk of peripheral neuropathy | 0 | 0 |
| 1153 | 4 | 7 | 2538 2003 NEUROLOGY 60(5):877-878 Giannini F; Volpi N; Rossi S; Passero S; Fimiani M; Cerase A Thalidomide-induced neuropathy: a ganglionopathy? | 3 | 3 |
| 1154 | 4 | 19 | 2563 2003 SYNTHETIC COMMUNICATIONS 33(8):1375-1382 Chang MY; Chen ST; Chang NC A synthesis of racemic thalidomide | 0 | 4 |
| 1155 | 4 | 5 | 2600 2004 BRITISH JOURNAL OF HAEMATOLOGY 125(1):96-97 Fakhouri F; Guerraoui H; Presne C; Peltier J; Delarue R; Muret P; Knebelmann B Thalidomide in patients with multiple myeloma and renal failure | 0 | 0 |
| 1156 | 4 | 22 | 2622 2004 EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES 21(4):465-469 Abraham MH Hydrogen bond and other descriptors for thalidomide and its N-alkyl analogs; prediction of physicochemical and biological properties | 0 | 0 |
| 1157 | 4 | 13 | 2659 2004 LEUKEMIA & LYMPHOMA 45(1):179-181 Baird R; van Zyl-Smit RN; Iveson A; Duddy J; Rassam S Thalidomide is highly effective in a patient with meningeal acute myeloid leukaemia | 0 | 0 |
| 1158 | 3 | 9 | 20 1961 BRITISH MEDICAL JOURNAL 2(525):855-& FULLERTON PM; KREMER M NEUROPATHY AFTER INTAKE OF THALIDOMIDE (DISTAVAL) | 61 | 87 |
| 1159 | 3 | 5 | 21 1961 BRITISH MEDICAL JOURNAL 2(525):876-& [Anon] THALIDOMIDE NEUROPATHY | 1 | 0 |
| 1160 | 3 | 6 | 69 1962 BRITISH MEDICAL JOURNAL (5305):646-& WARD SP THALIDOMIDE AND CONGENITAL ABNORMALITIES | 3 | 3 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1161 | 3 | 5 | 81 1962 BRITISH MEDICAL JOURNAL (5317):1447-& LECUTIER MA PHOCOMELIA AND INTERNAL DEFECTS DUE TO THALIDOMIDE | 0 | 0 |
| 1162 | 3 | 7 | 88 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 86(16):744-& RODIN AE; KOLLER LA; TAYLOR JD ASSOCIATION OF THALIDOMIDE (KEVADON) WITH CONGENITAL ANOMALIES | 8 | 13 |
| 1163 | 3 | 6 | 90 1962 CANADIAN MEDICAL ASSOCIATION JOURNAL 87(12):670-& IVES EJ THALIDOMIDE AND ANAL ABNORMALITIES | 1 | 8 |
| 1164 | 3 | 10 | 172 1962 PRESSE MEDICALE 70(31):1521-& TUCHMANNDUPLESSIS A PROPOS DES MALFORMATIONS ATTRIBUEES A UN SOMNIFERE LA THALIDOMIDE | 0 | 0 |
| 1165 | 3 | 24 | 199 1963 BRITISH MEDICAL JOURNAL (536):973-& BUCKLE RM BLOOD PYRUVIC ACID IN THALIDOMIDE NEUROPATHY | 0 | 0 |
| 1166 | 3 | 13 | 226 1963 LANCET 1(727):249-& ROATH S; ELVES MW; ISRAELS MCG EFFECTS OF THALIDOMIDE AND ITS DERIVATIVES ON HUMAN LEUCOCYTES CULTURED IN VITRO | 47 | 66 |
| 1167 | 3 | 14 | 233 1963 LANCET 1(728):724-& ROSENDAL T THALIDOMIDE AND APLASIA-HYPOPLASIA OF OTIC LABYRINTH | 0 | 7 |
| 1168 | 3 | 8 | 242 1963 LANCET 2(730):405-& LINDAHLKIESSLIN.K; BOOK JA EFFECTS OF THALIDOMIDE ON HUMAN LEUCOCYTE CULTURES | 16 | 23 |
| 1169 | 3 | 12 | 261 1963 SCIENCE 139(355):110-& FRANK O; LEEVY CM; HUTNER SH; BAKER H; ZIFFER H; AARONSON S METABOLIC DEFICIENCIES IN PROTOZOA INDUCED BY THALIDOMIDE | 25 | 43 |
| 1170 | 3 | 7 | 262 1963 SCIENCE 139(356):1295-& LUCEY JF; BEHRMAN RE THALIDOMIDE - EFFECT UPON PROGNANCY IN RHESUS MONKEY | 17 | 37 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1171 | 3 | 8 | 266 1964 ANALYTICAL BIOCHEMISTRY 8(1):129-& SANDBERG DH; TURNER DA; BOCK SA QUANTITATIVE MEASUREMENT OF THALIDOMIDE BY GAS-LIQUID CHROMATOGRAPHY | 2 | 4 |
| 1172 | 3 | 19 | 286 1964 JOURNAL OF REPRODUCTION AND FERTILITY 8(1):59-& HAY MF EFFECTS OF THALIDOMIDE ON PREGNANCY IN RABBIT | 9 | 30 |
| 1173 | 3 | 7 | 290 1964 LIFE SCIENCES 3(9):987-992 FABRO S; SCHUMACHER H; SMITH RL; WILLIAMS RT TERATOGENIC ACTIVITY OF THALIDOMIDE AND RELATED COMPOUNDS | 20 | 34 |
| 1174 | 3 | 4 | 296 1964 NEW ENGLAND JOURNAL OF MEDICINE 271(9):441-& INGALLS TH; ZAPPASODI P; CURLEY FJ THALIDOMIDE EMBRYOPATHY IN HYPRID RABBITS | 6 | 13 |
| 1175 | 3 | 7 | 298 1964 POULTRY SCIENCE 43(2):506-& BOONE MA; BARNETT BD; HAMMOND M EFFECT OF THALIDOMIDE ON CHICKENS + EMBRYOS | 1 | 3 |
| 1176 | 3 | 10 | 304 1965 ACTA CHEMICA SCANDINAVICA 19(5):1266-& FURBERG S STRUCTURAL RELATIONSHIP BETWEEN THALIDOMIDE AND NUCLEOSIDES | 8 | 13 |
| 1177 | 3 | 13 | 312 1965 ARCHIVES OF DISEASE IN CHILDHOOD 40(210):154-& MAIER WA THALIDOMIDE EMBRYOPATHY AND LIMB DEFECTS - EXPERIENCES IN HABILITATION OF CHILDREN WITH ECTROMELIAS | 0 | 1 |
| 1178 | 3 | 5 | 331 1965 COMPTES RENDUS DES SEANCES DE LA SOCIETE DE BIOLOGIE ET DE SES FILIALES 159(5):1059-& CAHEN CRR; DUPUIS R MALFORMATIONS VISCERALES PROVOQUEES PAR LE THALIDOMIDE CHEZ LE LAPIN | 0 | 0 |
| 1179 | 3 | 12 | 338 1965 JOURNAL OF EMBRYOLOGY AND EXPERIMENTAL MORPHOLOGY 13:235-& MARINPAD.M; BENIRSCH.K THALIDOMIDE INJURY TO MYOCARDIUM OF ARMADILLO EMBRYOS | 0 | 4 |
| 1180 | 3 | 4 | 345 1965 NATURE 205(4971):621-& LORKIEWI.Z; DUDEK M; ZIEMIECK.J STIMULATION OF TRANSFORMATION BY THALIDOMIDE | 0 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1181 | 3 | 5 | 389 1966 LANCET 1(7428):92-& BOHM R; NITSCH K ANOTHER CHANCE FOR THALIDOMIDE | 1 | 1 |
| 1182 | 3 | 10 | 395 1966 LANCET 1(7447):1134-& TURK JL; HELLMANN K; DUKE DI EFFECT OF THALIDOMIDE ON IMMUNOLOGICAL RESPONSE IN LOCAL LYMPH NODES AFTER A SKIN HOMOGRAFT | 28 | 32 |
| 1183 | 3 | 4 | 409 1966 SCIENCE 154(3754):1362-& SCHUMACHER H; BLAKE D; GILLETTE J; WUEST HM; FOX RR THALIDOMIDE SOLUTIONS | 7 | 7 |
| 1184 | 3 | 27 | 416 1967 AMERICAN JOURNAL OF VETERINARY RESEARCH 28(127):1829-& SZABO KT; STEELMAN RL EFFECTS OF THALIDOMIDE TREATMENT OF INBRED FEMALE MICE ON PREGNANCY FETAL DEVELOPMENT AND MORTALITY OF OFFSPRING | 2 | 2 |
| 1185 | 3 | 9 | 423 1967 BIOCHEMICAL JOURNAL 104(2):570-& FABRO S; SMITH RL; WILLIAMS RT FATE OF HYDROLYSIS PRODUCTS OF THALIDOMIDE IN PREGNANT RABBIT | 14 | 17 |
| 1186 | 3 | 8 | 452 1968 BRITISH JOURNAL OF EXPERIMENTAL PATHOLOGY 49(2):179-& VICKERS TH CARDIOVASCULAR MALFORMATIONS IN RABBIT THALIDOMIDE EMBRYOPATHY | 2 | 5 |
| 1187 | 3 | 10 | 459 1968 EXPERIENTIA 24(10):993-& WUEST HM; FOX RR; CRARY DD RELATIONSHIP BETWEEN TERATOGENY AND STRUCTURE IN THALIDOMIDE FIELD | 7 | 14 |
| 1188 | 3 | 15 | 462 1968 ISRAEL JOURNAL OF MEDICAL SCIENCES 4(4):901-& SHESKIN J; SAGHER F; DORFMAN M; VONSCHRA.HW UNSATISFACTORY RESULTS WITH THALIDOMIDE AS A SPECIFIC TREATMENT FOR LEPROSY | 13 | 13 |
| 1189 | 3 | 28 | 472 1968 TERATOLOGY 1(3):235-& GLOBUS M; GIBSON MA A HISTOLOGICAL AND HISTOCHEMICAL STUDY OF DEVELOPMENT OF STERNUM IN THALIDOMIDE-TREATED RATS | 6 | 18 |
| 1190 | 3 | 11 | 502 1970 EXPERIENTIA 26(3):305-& MIURA M; WUEST H POTENTIATING EFFECT OF THALIDOMIDE ON METHYLCHOLANTHRENE ONCOGENESIS IN MICE | 2 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 1191 | 3 | 18 | 508 1970 MIKROCHIMICA ACTA (3):530-& PISCHEK G; KAISER E; KOCH H THIN-LAYER CHROMATOGRAPHY OF THALIDOMIDE AND ITS HYDROLYSIS PRODUCTS | 6 | 12 |
| 1192 | 3 | 11 | 515 1971 ARZNEIMITTEL-FORSCHUNG 21(12):2022-& KOCH H; STOCKING.L TERATOLOGY STUDY ON 3-(1,4-ENDOXO-CYCLOHEXANE-2-EXO-3-EXO-DICARBOXIMIDO)-PIPERIDINE-2,6-DIONE (K-2604), ANOTHER COMPOUND WITH SEDATIVE-HYPNOTIC ACTIVITY AND STRUCTURALLY RELATED TO THALIDOMIDE | 2 | 4 |
| 1193 | 3 | 14 | 518 1971 BULLETIN OF THE WORLD HEALTH ORGANIZATION 45(6):719-& IYER CGS; LANGUILL.J; UEMURA K; TARABINI.G; SUNDARES.T; BECHELLI LM; DOMINGUE.VM; DELASAGU.JT; RAMANUJA.K WHO COORDINATED SHORT-TERM DOUBLE-BLIND TRIAL WITH THALIDOMIDE IN TREATMENT OF ACUTE LEPRA REACTIONS IN MALE LEPROMATOUS PATIENTS | 62 | 72 |
| 1194 | 3 | 15 | 571 1973 JOURNAL OF MEDICAL PRIMATOLOGY 2(5):267-276 HENDRICK.AG SENSITIVE PERIOD AND MALFORMATION SYNDROME PRODUCED BY THALIDOMIDE IN CRAB-EATING MONKEY (MACACA-FASCICULARIS) | 0 | 10 |
| 1195 | 3 | 12 | 576 1973 LANCET 2(7837):1058-1061 MCCREDIE J THALIDOMIDE AND CONGENITAL CHARCOTS JOINTS | 8 | 49 |
| 1196 | 3 | 5 | 621 1976 EXPERIENTIA 32(5):597-599 STOKES PA; LYKKE AWJ; MCBRIDE WG ULTRASTRUCTURAL CHANGES IN DORSAL ROOT-GANGLIA EVOKED BY THALIDOMIDE IN RABBITS | 0 | 3 |
| 1197 | 3 | 28 | 623 1976 INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY 14(3):258-262 PALAYOOR T; RAVEENDRAN P; BATRA BK RESPONSES OF PRE-IMPLANTATION MOUSE EMBRYOS TO THALIDOMIDE EXPOSURE INUTERO | 0 | 0 |
| 1198 | 3 | 14 | 641 1977 ARCHIVES OF TOXICOLOGY 37(2):165-172 JURECKA W; LASSMANN H; STOCKINGER L TERATOLOGIC-NEUROTOXIC EXAMINATION OF BIGLUMIDE (K-2004) AND THALIDOMIDE | 1 | 3 |
| 1199 | 3 | 8 | 661 1977 TERATOLOGY 16(3):333-335 SCOTT WJ; FRADKIN R; WILSON JG NON-CONFIRMATION OF THALIDOMIDE INDUCED TERATOGENESIS IN RATS AND MICE | 18 | 32 |
| 1200 | 3 | 36 | 668 1978 INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY 57(4):317-332 GOIHMANYAHR M; CONVIT J; RODRIGUEZOCHOA G; ARANZAZU N; VILLALBAPIMENTEL L; OCANTO A; ELENADEGOMEZ M SIGNIFICANCE OF NEUTROPHIL ACTIVATION IN REACTIONAL LEPROMATOUS LEPROSY - EFFECTS OF THALIDOMIDE INVIVO AND INVITRO - ACTIVATION IN ADJUVANT DISEASE | 14 | 23 |
Page 4: 1 2 3 4 5 6 7 8 9
Generated by: HistCite(Vlad).
Version: 2004.09.22